1. Complement factor H inhibits endothelial cell migration through suppression of STAT3 signaling
   Jiang Li et al, 2023, Experimental and Therapeutic Medicine CrossRef
2. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma
   Yuxi Cheng et al, 2024, Clinical Epigenetics CrossRef
3. 4-Oxo-fenretinide-Loaded Human Serum Albumin Nanoparticles for the Inhibition of Epithelial–Mesenchymal Transition in Neuroblastoma Xenografts
   Atul Dev et al, 2022, ACS Applied Nano Materials CrossRef
4. H3F3A K27M Mutation Promotes the Infiltrative Growth of High-Grade Glioma in Adults by Activating β-Catenin/USP1 Signaling
   Zhiyuan Sun et al, 2022, Cancers CrossRef
5. The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1
   Jolien Fledderus et al, 2021, Journal of Personalized Medicine CrossRef
6. Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
   Kyunghee Burkitt et al, 2021, Cancers CrossRef